Male, n(%)	82 (56)
Age (years), median(IQR)	64 (55–73)
Renal failure, eGFR <60 mL/min	10 (7)
Immunosuppression, n(%)	31 (21)
Gastrointestinal surgery, n(%)	126 (86)
Necrotizing pancreatitis, n(%)	20 (14)
Clinical data at T2Candida/BDG testing
SOFA score, ±SD	3.9 ± 3.5
Vasopressor treatment, n(%)	54 (37)
>1 Gastrointestinal surgery, n(%)	27 (18)
Days in intensive/intermediate care, median (IQR)	3.5 (1–6)
Mechanical ventilation, n(%)	39 (27)
Total parental nutrition, n(%)	43 (29)
Renal replacement therapy, n(%)	15 (10)
Broad spectrum antibiotic therapy, n(%)	84 (58)
Antifungal therapy, n(%)	18 (12.3)
30-day mortality, n(%)	21 (14)